1Outpatient clinic, Second General Hospital
2Department of Epidemiology and Biostatistics, HSUM
3School of Medicine, HSUM
4Department of Nephrology, HSUM
Өгүүллийн PDF-ийг татах
International Diabetes Federation estimates that 246 million people around the world have diabetes. For Type 2 DM, revealing of microalbuminuria expresses not only nephropathy but also the risk of cardio-vascular complications. Therefore, it becomes the indication to provide a cardiac examination. The aim of this study is to determine microalbumin in the urine with Type 2 DM. This study was conducted using hospital-based cross-sectional method. The subjects were selected from follow-up patients with Type 2 DM in endocrinology wards of the district health centers of 5 districts. General urine analysis and revealing of microalbumin was performed in fasting blood. The general analysis in the urine was determined by total protein excretion. Microalbuminuria analysis was conducted in 182 patients with no proteinuria. Microalbumin detection analysis in urine was repeated 3 times. Microalbuminuria analysis was conducted in 182 patients without proteinuria and the results of 23.1% (42) patients were positive, but 76.9% (140) were negative. Micro albumin amount in patients with positive results was ranged 20.2-187.0 mg/L. The analysis was repeated in 42 patients with microalbuminuria and 29 patients have positive results, but 13 have negative results. The micro albumin amount of urine in patients with positive results was 21.5-194 mg/L. The results of microalbuminuria were positive in males 57.6% and in females 42.4%. The mean age of patients with microalbuminuria was 62.6. Mean period of having DM in patients with no microalbuminuria was 6.1 years, but in patients with microalbuminuria 8.7 years. Microalbuminuria is occurred 1.8 times higher in patients-smokers than in patients who don’t smoke. In conclusion, microalbuminuria was revealed in 18.1% of patients on whom no protein detected in general urine analysis and amount of microalbumin of urine ranged between 20.2-187.0 mg/L.
Geneva.
2.Suvd J. Prediabetes diagnosis and intervention lifestyle. Mongolian Diabetes International Conference. 2010.
3.Dedov II, Shestakova MB. Diabetic nephropathy. 2000; 46-98.
4. Brenner Rectors. Diabetic Nephropathy. The Kidney: 2008; 1265-1289
5.John Feehally, Jurgen Floege, Richard Johnson. Prevention and Treatment of Diabetic Nephropathy. Compreh Clin Nephrol. 2007; 353-363
6.David Windus, Katherine E, Henderson Thomas M, De Fer; Nephrology Subspeciality Consult 2008; 193-199.
7. Davison Alex M, Cameron J Stewart, Grunfeld Jean-Pierre, Ponticelli Claudio, Ritz Eberhard, Winearis Christopher G, Ypersele Charies Van. Oxford Textbook of clinical Nephrology. 2005, 658-670.
8. Campos-Pastor MM, Escobar-Jimenez F, Mezduita P, Herrera-Pombo JL, Hawkins-Garranza F.Luna JD, Azriel S, Serraclara A, Rigopoulos M. Factors associated with microalbuminuria in type 1 diabetes mellitus. Diabet Res Clin Practice.2000;48:43-4.
9. Cederholm J, Eliasson B, Nillson PM, Weiss L, Gudbjornsdottir S. Microalbuminuria and risk factors in type 1 and 2 diabetic patients. Diabet Res Clin Practice. 2005;67;258-266.
10.Weiping J, Xin G, Can P, Xuhong H, Yuqian B, Wei L, Wenxia W, Yuhua Z, Huilin G, Kunsan X. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation. Nephrol Dial Transplant. 2009;24:3724-3731.
11.Kim YI, Kim C-H., Choi C S., Chung Y E., Lee M S., Lee S I., Park J Y., Hong S K., Lee K.-U. Microalbuminuria is associated with insulin resistance.Syndrome independent of hypertension and type 2 diabetes in Korean Population. Diabetes Res Clinical Practice.2001;52;145-152.
12. Loek T J Pijls., Hendrik de Vries., Didi M. W. Kriegsman., Ab J.M.Donker. Jacquis ThM van Eijk. Determinants of albuminuria in people with Type 2 Diabetes mellitus. Diabetes research and clinical practice.2011;52:132-143.
13.Pan C Y., Ho L T., Soegondo S., Prodjosudjadi W., Suwanwalaikorn s., Lim S C., Chan T M., Chou K W; Thoenes M., Choi D S. Prevalence of albuminuia and cardiovascular risk profile in a referred cohort oa patients with type 2 diabetes:Asian perspective.Diabetes Technol Ther:2008:10(5):397-403.
14.Erdenekhuu N., Determinants of microalbuminuria and HbA1c in diabetic patients.Thesis for master of medical science.2002.
15.Salman R A., Basri H A., Sayyad A S., Hearnshaw HM., Prevalence and risk factors of albuminuria in Type 2 diabetes in Bahrain. J Endocrinol Invest. 2009; 32(9):746-751.
